Download PDF
Pharmacopsychiatry 2016; 49(01): 18-22
DOI: 10.1055/s-0035-1565204
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Elevated Rest Heart Rate in Psychiatric Patients and Different Effects of Psychotropic Medication

J. Sarlon
1   Department of Psychiatry, University Hospital Frankfurt am Main, Germany
,
O. Habich
2   Department of Internal and Geriatric Medicine, Diakonissen Hospital Frankfurt am Main, Germany
,
B. Schneider
3   Department of Addictive Disorders, Landschaftsverband Rheinland Clinic Cologne, Germany
› Author Affiliations
Further Information

Publication History

received 12 April 2015
revised 10 October 2015

accepted 27 October 2015

Publication Date:
02 December 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction: Elevated rest heart rate (RHR) is a known risk factor of cardiovascular diseases. The aim of this study was to analyse the effects of different psychiatric disorders and psychotropic medication on RHR.

Methods: In this retrospective study, medical records of 590 inpatients with a psychiatric disorder (309 men, 281 women, mean age 42.11; SD=13.8 years) were evaluated. RHR, the psychiatric diagnosis according to ICD-10, the psychotropic medication and the use of beta blockers were assessed.

Results: The average RHR of all patients was 85.62 beats per minute (bpm) (SD=10.60 bpm) which is, according to the literature and the consensus of experts, to be considered as a relevant elevation of RHR. There was a significant negative correlation between age and RHR. Patients treated with monotherapy or with SSRI showed in the multiple regression analysis significant lower RHR than other subjects, whereas both polytherapy with more antipsychotics and the diagnosis of schizophrenia could be identified as an independent risk factor of elevated RHR (p<0.05, 2-tailed). The presence of hypertonia, diabetes, hypercholesterolemia or obesity has no influence on RHR. 6% of the study population received beta blocker during the hospitalization.

Discussion: The elevated RHR in psychiatric patients is a common phenomenon and can be observed independently of the use of psychotropic medication but more in patients with schizophrenia. An interesting additional finding could be a possible protective effect of SSRI on RHR in psychiatric patients.

Key words

antipsychotic drugs - schizophrenia - selective serotonin reuptake inhibitors - (SSRIs) - stress
 

  • References

  • 1 Ji C, Zheng X, Chen S et al. Impact of resting heart rate on the progression to hypertension in prehypertension patients. Zhonghua Xin Xue Guan Bing Za Zhi 2014; 42: 860-865
    PubMedGoogle Scholar
  • 2 Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. Hypertension 2011; 58: 745-750
    CrossrefPubMedGoogle Scholar
  • 3 Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men?. Ann Med 2001; 33: 213-221
    CrossrefPubMedGoogle Scholar
  • 4 Pfister R, Michels G, Sharp SJ et al. Resting heart rate and incident heart failure in apparently healthy men and women in the EPIC-Norfolk study. Eur J Heart Fail 2012; 14: 1163-1170 Epub 2012 Jun 26
    CrossrefPubMedGoogle Scholar
  • 5 Palatini P, Mos L, Santonastaso M et al. Resting heart rate as a predictor of body weight gain in the early stage of hypertension. Obesity 2011; 19: 618-623
    CrossrefPubMedGoogle Scholar
  • 6 Shigetoh Y, Adachi H, Yamagishi S et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22: 151-155
    CrossrefPubMedGoogle Scholar
  • 7 Custodis F, Schirmer SH, Baumhäkel M et al. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol 2010; 56: 1973-1983
    CrossrefPubMedGoogle Scholar
  • 8 Masuo K, Kawaguchi H, Mikami H et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480
    CrossrefPubMedGoogle Scholar
  • 9 Palatini P, Longo D, Zaetta V et al. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 2006; 24: 1375-1381
    CrossrefPubMedGoogle Scholar
  • 10 Palatini P, Benetos A, Grassi G et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24: 603-610
    CrossrefPubMedGoogle Scholar
  • 11 Perret-Guillaume C, Joly L, Benetos A. Heart rate as a risk factor for cardiovascular disease. Prog Cardiovasc Dis 2009; 52: 6-10
    CrossrefPubMedGoogle Scholar
  • 12 King DE, Everett CJ, Mainous 3rd AG et al. Long-term prognostic value of resting heart rate in subjects with prehypertension. Am J Hypertens 2006; 19: 796-800
    CrossrefPubMedGoogle Scholar
  • 13 Okin PM, Kjeldsen SE, Julius S et al. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. Eur Heart J 2010; 31: 2271-2279
    CrossrefPubMedGoogle Scholar
  • 14 Palatini P, Thijs L, Staessen JA et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313-2321
    CrossrefPubMedGoogle Scholar
  • 15 Paul L, Hastie CE, Li WS et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients. Hypertension 2010; 55: 567-574
    CrossrefPubMedGoogle Scholar
  • 16 Lonn EM, Rambihar S, Gao P et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Circulation 2010; 122: A12667
    PubMedGoogle Scholar
  • 17 Nauman J, Janszky I, Vatten LJ et al. Temporal Changes in Resting Heart Rate and Deaths From Ischemic Heart Disease. JAMA 2011; 306: 2579-2587
    CrossrefPubMedGoogle Scholar
  • 18 Bjerregaard P. Mean 24 hour heart rate, minimal heart rate and pauses in healthy subjects 40–79 years of age. Eur Heart J 1983; 4: 44-51
    PubMedGoogle Scholar
  • 19 Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 2005; 26: 469-500
    CrossrefPubMedGoogle Scholar
  • 20 Lin HP, Lin HY, Lin WL et al. Effects of stress, depression, and their interaction on heart rate, skin conductance, finger temperature, and respiratory rate: sympathetic-parasympathetic hypothesis of stress and depression. J Clin. Psychol 2000; 67: 1080-1091
    PubMedGoogle Scholar
  • 21 Bär KJ, Rachow T, Schulz S et al The phrenic component of acute schizophrenia – a name and its physiological reality. PloS One 2012; 7: e33459
    CrossrefPubMedGoogle Scholar
  • 22 Kamphuis MH, Geerlings MI, Giampaoli S et al. The association of depression with cardiovascular mortality is partly explained by health status. The FINE Study. J Affect Disord 2009; 114: 184-192
    CrossrefPubMedGoogle Scholar
  • 23 Lee K, Park J, Choi J et al. Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J Korean Acad Nurs 2011; 41: 788-794
    CrossrefPubMedGoogle Scholar
  • 24 Leistedt SJ, Linkowski P, Lanquart JP et al. Decreased neuroautonomic complexity in men during an acute major depressive episode: analysis of heart rate dynamics. Transl Psychiatry 2011; 1: e27
    CrossrefPubMedGoogle Scholar
  • 25 Lo Turco G, Grimaldi Di Terresena L. Spectral analysis of Heart Rate Variability in psychiatric patients: autonomic nervous system evaluation in psychotic, anxiety and depressive disorders. Riv Psichiatr 2012; 47: 139-148
    PubMedGoogle Scholar
  • 26 O'Keefe JH, Bhatti SK, Bajwa A et al. Alcohol and cardiovascular health: the dose makes the poison…or the remedy. Mayo Clin Proc 2014; 89: 382-393
    CrossrefPubMedGoogle Scholar
  • 27 Potter WZ, Manji HK. Catecholamines in depression: an update. Clin Chem 1994; 40: 279-287
    PubMedGoogle Scholar
  • 28 Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12 (Suppl. 01) 2-19
    CrossrefPubMedGoogle Scholar
  • 29 Salaycik KJ, Kelly-Hayes M, Beiser A et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke 2007; 38: 16-21 Epub 2006 Nov 30
    CrossrefPubMedGoogle Scholar
  • 30 Shi S, Liang J, Liu T et al. Depression increases sympathetic activity and exacerbates myocardial remodeling after myocardial infarction: evidence from an animal experiment. PloS One 2014; 9: e101734
    CrossrefPubMedGoogle Scholar
  • 31 Yamanaka G, Otsuka K, Hotta N et al. Depressive mood is independently related to stroke and cardiovascular events in a community. Biomed Pharmacother 2005; 59 (Suppl. 01) S31-S319
    CrossrefPubMedGoogle Scholar
  • 32 Kemp AH, Quintana DS, Quinn CR et al. Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality. Front Psychol 2014; 5: 1387 DOI: 10.3389/fpsyg.2014.01387. ECollection 2014
    PubMedGoogle Scholar
  • 33 Everson-Rose SA, House JS, Mero RP. Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 2004; 66: 823-830
    CrossrefPubMedGoogle Scholar
  • 34 Fujibayashi M, Matsumoto T, Kishida I et al. Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin Neurosci 2009; 63: 538-545
    CrossrefPubMedGoogle Scholar
  • 35 Iwamoto Y, Kawanishi C, Kishida I et al. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia. BMC Psychiatry 2012; 12: 199
    CrossrefPubMedGoogle Scholar
  • 36 Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol 2003; 23: 58-77
    CrossrefPubMedGoogle Scholar
  • 37 Agelink MW, Majewski T, Wurthmann C et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001; 21: 8-13
    CrossrefPubMedGoogle Scholar
  • 38 Cohen H, Loewenthal U, Matar M et al. Heart rate variability in schizophrenic patients treated with antipsychotic agents. Harefuah 2001; 140: 1142-1147 1231
    PubMedGoogle Scholar
  • 39 Eschweiler GW, Bartels M, Längle G et al. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002; 35: 96-100
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Suttajit S, Srisurapanont M, Xia J et al. Quetiapine versus typical antipsychotic medications for schizophrenia. Cochrane Database Syst Rev 2013; 5 CD007815 Doi: DOI: 10.1002/14651858.CD007815.pub2.
    PubMedGoogle Scholar
  • 41 Moser M, Lehofer M, Hoehn-Saric R et al. Increased heart rate in depressed subjects in spite of unchanged autonomic balance. J Affect Disord 1998; 48: 115-124
    CrossrefPubMedGoogle Scholar
  • 42 Lehofer M, Moser M, Hoehn-Saric R et al. Influence of age on the parasympatholytic property of tricycklic antidepressants. Psychiatry Res 1999; 85: 199-207
    CrossrefPubMedGoogle Scholar
  • 43 Scalco AZ, Rondon MU, Trombetta IC et al. Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. J Hypertens 2009; 27: 2429-2436
    CrossrefPubMedGoogle Scholar
  • 44 Davies SJ, Jackson PR, Ramsay LE et al. No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens (Greenwich) 2003; 5: 145-152
    CrossrefPubMedGoogle Scholar
  • 45 Bangalore S, Fh Messerli, Kostis JB et al. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiolog 2007; 50: 563-72 Epub 2007 Jul 30
    PubMedGoogle Scholar